share_log

Indaptus Therapeutics Analyst Ratings

インダプタス・セラピューティクスのアナリスト評価

Benzinga ·  2023/08/11 07:13
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/11/2023 442.99% HC Wainwright & Co. → $12 Reiterates Buy → Buy
08/08/2023 442.99% HC Wainwright & Co. → $12 Reiterates Buy → Buy
05/04/2023 442.99% HC Wainwright & Co. → $12 Reiterates → Buy
03/20/2023 442.99% HC Wainwright & Co. $15 → $12 Maintains Buy
03/08/2023 578.73% HC Wainwright & Co. → $15 Reiterates → Overweight
02/08/2023 578.73% HC Wainwright & Co. → $15 Reiterates → Buy
01/31/2022 578.73% HC Wainwright & Co. → $15 Assumes → Buy
10/19/2021 623.98% Maxim Group → $16 Upgrades Hold → Buy

What is the target price for Indaptus Therapeutics (INDP)?

The latest price target for Indaptus Therapeutics (NASDAQ: INDP) was reported by HC Wainwright & Co. on August 11, 2023. The analyst firm set a price target for $12.00 expecting INDP to rise to within 12 months (a possible 442.99% upside). 6 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Indaptus Therapeutics (INDP)?

The latest analyst rating for Indaptus Therapeutics (NASDAQ: INDP) was provided by HC Wainwright & Co., and Indaptus Therapeutics reiterated their buy rating.

When is the next analyst rating going to be posted or updated for Indaptus Therapeutics (INDP)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Indaptus Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Indaptus Therapeutics was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.

Is the Analyst Rating Indaptus Therapeutics (INDP) correct?

While ratings are subjective and will change, the latest Indaptus Therapeutics (INDP) rating was a reiterated with a price target of $0.00 to $12.00. The current price Indaptus Therapeutics (INDP) is trading at is $2.21, which is within the analyst's predicted range.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする